|
FBXL17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62858615482264E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64768199084619E-12 |
| Normal-vs-Stage2 |
1.856050E-03 |
| Normal-vs-Stage3 |
2.35009999999258E-05 |
| Normal-vs-Stage4 |
5.53660000068845E-08 |
| Stage1-vs-Stage2 |
4.538400E-01 |
| Stage1-vs-Stage3 |
9.342000E-01 |
| Stage1-vs-Stage4 |
6.139600E-01 |
| Stage2-vs-Stage3 |
6.043200E-01 |
| Stage2-vs-Stage4 |
3.626400E-01 |
| Stage3-vs-Stage4 |
6.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88737914186277E-15 |
| Normal-vs-AfricanAmerican |
9.0824999743333E-09 |
| Normal-vs-Asian |
9.010100E-02 |
| Caucasian-vs-AfricanAmerican |
4.913000E-01 |
| Caucasian-vs-Asian |
9.185600E-01 |
| AfricanAmerican-vs-Asian |
7.502400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.07370000002049E-07 |
| Male-vs-Female |
9.960100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.28609999999951E-06 |
| Normal-vs-Extreme_Weight |
2.18391971174015E-12 |
| Normal-vs-Obese |
1.98279948016022E-10 |
| Normal-vs-Extreme_Obese |
1.862870E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.715400E-01 |
| Normal_Weight-vs-Obese |
8.174400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.716200E-01 |
| Extreme_Weight-vs-Obese |
2.991800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.886800E-01 |
| Obese-vs-Extreme_Obese |
8.992800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.57150000018791E-07 |
| Normal-vs-Age(41-60Yrs) |
1.04759534380605E-11 |
| Normal-vs-Age(61-80Yrs) |
6.99440505513849E-15 |
| Normal-vs-Age(81-100Yrs) |
6.71650002281865E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.284300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.545800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.532000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.831420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.143200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
2.21729999999587E-05 |
| Normal-VS-KIRP CIMP |
1.64646074551911E-12 |
| Normal-VS-Unclassified PRCC |
1.82590000008531E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.791760E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.21519999999265E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.645600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.86930000034558E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
2.865600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.4835999999917E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4209999843473E-09 |
| Normal-vs-N1 |
1.56460000511061E-08 |
| Normal-vs-N2 |
2.11229999999007E-05 |
| N0-vs-N1 |
4.253200E-01 |
| N0-vs-N2 |
7.503600E-01 |
| N1-vs-N2 |
9.503600E-01 |
|
|
